FDA clears ImmersiveTouch augmented reality surgical system

ImmersiveTouch announced today that it received FDA 510(k) clearance for its ImmersiveAR augmented reality technology platform.

Chicago-based ImmersiveTouch’s ImmersiveAR extends the company’s AI-powered suite of virtual surgical planning products and services. The company’s portfolio aims to slim down the pre-operative planning workflow from seven days to just minutes. Surgeons can simulate surgical changes to bones and plan the final aesthetic result, tailoring the procedure to unique patient anatomies. This helps to minimize errors and complications.

ImmersiveAR allows surgeons to visualize and interact with 3D virtual surgical plans. They are overlaid in an operating room environment for a fully integrated workflow from surgical planning to intraoperative 3D visualization. Surgeons can double-check planned movements and reduce the need for intraoperative trial and error.

Sign up for Blog Updates